340 related articles for article (PubMed ID: 26188909)
1. Ferroquine and its derivatives: new generation of antimalarial agents.
Wani WA; Jameel E; Baig U; Mumtazuddin S; Hun LT
Eur J Med Chem; 2015 Aug; 101():534-51. PubMed ID: 26188909
[TBL] [Abstract][Full Text] [Related]
2. Trioxaferroquines as new hybrid antimalarial drugs.
Bellot F; Coslédan F; Vendier L; Brocard J; Meunier B; Robert A
J Med Chem; 2010 May; 53(10):4103-9. PubMed ID: 20443628
[TBL] [Abstract][Full Text] [Related]
3. Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.
Peter S; Aderibigbe BA
Molecules; 2019 Oct; 24(19):. PubMed ID: 31591298
[TBL] [Abstract][Full Text] [Related]
4. Ferroquine-derived polyamines that target resistant Plasmodium falciparum.
Stringer T; Wiesner L; Smith GS
Eur J Med Chem; 2019 Oct; 179():78-83. PubMed ID: 31238252
[TBL] [Abstract][Full Text] [Related]
5. Antimalarial activities of ferroquine conjugates with either glutathione reductase inhibitors or glutathione depletors via a hydrolyzable amide linker.
Chavain N; Davioud-Charvet E; Trivelli X; Mbeki L; Rottmann M; Brun R; Biot C
Bioorg Med Chem; 2009 Dec; 17(23):8048-59. PubMed ID: 19864147
[TBL] [Abstract][Full Text] [Related]
6. The antimalarial ferroquine: from bench to clinic.
Biot C; Nosten F; Fraisse L; Ter-Minassian D; Khalife J; Dive D
Parasite; 2011 Aug; 18(3):207-14. PubMed ID: 21894260
[TBL] [Abstract][Full Text] [Related]
7. Structural characteristics of chloroquine-bridged ferrocenophane analogues of ferroquine may obviate malaria drug-resistance mechanisms.
Salas PF; Herrmann C; Cawthray JF; Nimphius C; Kenkel A; Chen J; de Kock C; Smith PJ; Patrick BO; Adam MJ; Orvig C
J Med Chem; 2013 Feb; 56(4):1596-613. PubMed ID: 23327489
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border.
Barends M; Jaidee A; Khaohirun N; Singhasivanon P; Nosten F
Malar J; 2007 Jun; 6():81. PubMed ID: 17597537
[TBL] [Abstract][Full Text] [Related]
9. Ferrocene conjugates of chloroquine and other antimalarials: the development of ferroquine, a new antimalarial.
Dive D; Biot C
ChemMedChem; 2008 Mar; 3(3):383-91. PubMed ID: 17806092
[No Abstract] [Full Text] [Related]
10. Design and synthesis of novel ferrocene-quinoline conjugates and evaluation of their electrochemical and antiplasmodium properties.
Minić A; Van de Walle T; Van Hecke K; Combrinck J; Smith PJ; Chibale K; D'hooghe M
Eur J Med Chem; 2020 Feb; 187():111963. PubMed ID: 31865015
[TBL] [Abstract][Full Text] [Related]
11. Probing the role of the covalent linkage of ferrocene into a chloroquine template.
Biot C; Daher W; Ndiaye CM; Melnyk P; Pradines B; Chavain N; Pellet A; Fraisse L; Pelinski L; Jarry C; Brocard J; Khalife J; Forfar-Bares I; Dive D
J Med Chem; 2006 Jul; 49(15):4707-14. PubMed ID: 16854077
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, and Evaluation of Novel Ferroquine and Phenylequine Analogues as Potential Antiplasmodial Agents.
Jacobs L; de Kock C; de Villiers KA; Smith PJ; Smith VJ; van Otterlo WA; Blackie MA
ChemMedChem; 2015 Dec; 10(12):2099-110. PubMed ID: 26447782
[TBL] [Abstract][Full Text] [Related]
13. Ferrocene Derivatives as New Generation of Antimalarial Agents: Opportunity or Illusion?
Mangawa SK; Singh S
Curr Top Med Chem; 2023; 23(16):1503-1521. PubMed ID: 36852796
[TBL] [Abstract][Full Text] [Related]
14. Current scenario of ferrocene-containing hybrids for antimalarial activity.
Xiao J; Sun Z; Kong F; Gao F
Eur J Med Chem; 2020 Jan; 185():111791. PubMed ID: 31669852
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium vivax susceptibility to ferroquine.
Leimanis ML; Jaidee A; Sriprawat K; Kaewpongsri S; Suwanarusk R; Barends M; Phyo AP; Russell B; Renia L; Nosten F
Antimicrob Agents Chemother; 2010 May; 54(5):2228-30. PubMed ID: 20308387
[TBL] [Abstract][Full Text] [Related]
16. Ferrocene-pyrimidine conjugates: Synthesis, electrochemistry, physicochemical properties and antiplasmodial activities.
Chopra R; de Kock C; Smith P; Chibale K; Singh K
Eur J Med Chem; 2015 Jul; 100():1-9. PubMed ID: 26057222
[TBL] [Abstract][Full Text] [Related]
17. 4-Aminoquinoline-ferrocene Hybrids as Potential Antimalarials.
Nqoro X; Aderibigbe BA
Recent Pat Antiinfect Drug Discov; 2020; 15(2):157-172. PubMed ID: 32753021
[TBL] [Abstract][Full Text] [Related]
18. Ferroquine as an oxidative shock antimalarial.
Dive D; Biot C
Curr Top Med Chem; 2014; 14(14):1684-92. PubMed ID: 25116581
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of ferroquine against artemisinin-based combination therapy (ACT)-resistant Plasmodium falciparum isolates from Cambodia.
Mairet-Khedim M; Nardella F; Khim N; Kim S; Kloeung N; Ke S; Kauy C; Eam R; Khean C; Pellet A; Leboulleux D; Leang R; Ringwald P; Barale JC; Leroy D; Menard D; Witkowski B
J Antimicrob Chemother; 2019 Nov; 74(11):3240-3244. PubMed ID: 31518407
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum.
Kreidenweiss A; Kremsner PG; Dietz K; Mordmüller B
Am J Trop Med Hyg; 2006 Dec; 75(6):1178-81. PubMed ID: 17172389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
